Trademark Overview
On Tuesday, July 2, 2024, a trademark application was filed for CHACM PEP with the United States Patent and Trademark Office. The USPTO has given the CHACM PEP trademark a serial number of 98630286. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, April 7, 2025. This trademark is owned by RJK Biopharma Inc.. The CHACM PEP trademark is filed in the Pharmaceutical Products category with the following description:
Biological preparations for the treatment of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Biological tissue cultures for medical purposes; Collyrium; Medicinal drinks; Amino acids for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration; Enzyme preparations for medical purposes; Dietetic foods adapted for medical purposes; All the above-mentioned goods relating to neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration
